A previous article misstated that the Institute of Molecular Pathology (IMP) was seeking patents on transgenic mice experiments. This correction clarifies that no patent applications have been filed by IMP or its parent companies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: